Meghmani Organics cash flow

Latest FY26

Cash from operations: ₹222cr+234.9% on FY25
Capital spending: ₹45.1cr−49.3% on FY25
Free cash flow: ₹177cr−₹22.7 cr in FY25
Cash from financing: −₹190cr−₹91.4 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	119	108	92.2	77.1
	—	91.9	69.0	46.4	65.7
	—	−4.3	−0.6	−0.8	−1.2
	—	−0.0	−3.6	−11.5	−16.4
	—	−23.8	−1.7	5.9	−1.7
	—	−4.9	0.8	1.5	−19.3
	—	1.0	1.4	−1.3	1.3
	—	70.5	−81.8	129	25.5
	—	−74.6	−139	82.8	20.2
	—	4.2	41.0	−2.0	19.1
	—	2.0	−1.6	5.8	−3.9
	—	50.9	25.9	−0.3	−35.5
	—	−35.2	−28.3	−2.2	−0.7
	—	−12.4	63.2	45.3	−126
	—	4.2	1.8	−14.2	0.8
	—	−0.1	−0.2	−0.2	0.2
	—	−10.3	4.5	−1.0	−31.8
	—	10.0	1.7	2.5	1.3
Cash from operating activities
	105	62.0	9.5	−121	313
	—	188	60.8	378	−24.9
	—	250	70.3	257	288
	—	28.2	4.0	7.1	83.7
	—	222	66.2	250	204
Cash from investing activities
	—	45.1	88.9	266	465
	—	1.1	2.8	2.2	1.3
	—	0.0	95.0	55.0	60.9
	—	3.2	7.7	15.9	15.5
	—	4.3	3.6	0.7	2.5
	—	−1.9	10.7	14.0	−32.7
	—	−38.3	31.0	−178	−418
Cash from financing activities
	—	3.8	62.5	157	328
	—	107	71.7	143	14.4
	—	0.2	1.8	0.0	0.0
	—	—	—	1.8	1.8
	—	86.7	0.0	62.3	42.2
	—	0.0	0.0	35.6	35.6
	—	0.0	80.3	0.0	0.0
	—	−190	−91.4	−85.5	234
	—	−6.9	5.8	−14.2	20.6
	—	−6.9	5.8	−14.2	20.6
	—	—	—	16.9	31.1
Reference items
	207	176	143	−20.3	341
	9.9%	8.1%	6.9%	−1.3%	13.4%
	177	177	−22.7	−16.5	−261
	—	−13.1	—	−64.3	—
	₹6.95	₹6.95	−₹0.89	−₹0.65	−₹10.25
	7.92×	—	—	—	—
	—	7.72×	−6.25×	−2.35×	0.86×
	—	28.2	4.0	7.1	83.7
	—	86.7	—	62.3	42.2

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MOL₹55.04

Meghmani Organics Limited

· Chemicals

₹ CrorePeersIPL PUNJABCHEM INSECTICID ASTEC BHARATRAS DHARMAJ GSPCROP ADVANCEMcap ₹1,400 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	77.1	92.2	108.1	119.0	—
+ Finance Costs	65.7	46.4	69.0	91.9	—
+ Interest Income	-1.2	-0.8	-0.6	-4.3	—
+ Dividend Income	-16.4	-11.5	-3.6	-0.0	—
+ Unrealised FX (Gain) / Loss	-1.7	5.9	-1.7	-23.8	—
+ Other Non-cash Items	-19.3	1.5	0.8	-4.9	—
+ Other — Cash Effects are Investing / Financing	1.3	-1.3	1.4	1.0	—
Changes in Working Capital
+ Inventories	25.5	128.8	-81.8	70.5	—
+ Trade Receivables — Current	20.2	82.8	-138.6	-74.6	—
+ Other Financial Assets — Current	19.1	-2.0	41.0	4.2	—
+ Other Financial Assets — Non-current	-3.9	5.8	-1.6	2.0	—
+ Other Current Assets	-35.5	-0.3	25.9	50.9	—
+ Other Non-current Assets	-0.7	-2.2	-28.3	-35.2	—
+ Trade Payables — Current	-125.6	45.3	63.2	-12.4	—
+ Other Financial Liabilities — Current	0.8	-14.2	1.8	4.2	—
+ Other Financial Liabilities — Non-current	0.2	-0.2	-0.2	-0.1	—
+ Other Current Liabilities	-31.8	-1.0	4.5	-10.3	—
+ Provisions — Non-current	1.3	2.5	1.7	10.0	—
Cash from Operating Activities
Profit Before Tax (per I/S)	313.1	-121.2	9.5	62.0	104.7
+ Total Adjustments (incl. Working Capital)	-24.9	377.9	60.8	187.9	—
Cash from Operations (pre-tax)	288.2	256.8	70.3	249.9	—
+ Income Taxes Paid	83.7	7.1	4.0	28.2	—
Cash from Operating Activities	204.5	249.7	66.2	221.7	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	465.1	266.2	88.9	45.1	—
+ Disp of Fixed Assets	1.3	2.2	2.8	1.1	—
+ Sale of Investments (Equity / Debt)	60.9	55.0	95.0	0.0	—
+ Dividends Received — Investing	15.5	15.9	7.7	3.2	—
+ Interest Received — Investing	2.5	0.7	3.6	4.3	—
+ Other Inflows / (Outflows) — Investing	-32.7	14.0	10.7	-1.9	—
Cash from Investing Activities	-417.6	-178.4	31.0	-38.3	—
Cash from Financing Activities
+ Proceeds from Borrowings	327.8	157.5	62.5	3.8	—
+ Repayment of Borrowings	14.4	143.3	71.7	107.3	—
+ Payment of Lease Liabilities	0.0	0.0	1.8	0.2	—
+ Payment of Finance Lease Liabilities	1.8	1.8	—	—	—
+ Interest Paid	42.2	62.3	0.0	86.7	—
+ Dividends Paid	35.6	35.6	0.0	0.0	—
+ Income Taxes (Paid) / Refund — Financing	0.0	0.0	80.3	0.0	—
Cash from Financing Activities	233.7	-85.5	-91.4	-190.3	—
Net Changes in Cash (pre-FX)	20.6	-14.2	5.8	-6.9	—
Net Changes in Cash	20.6	-14.2	5.8	-6.9	—
Closing Cash	31.1	16.9	—	—	—
Reference Items
EBITDA	341.0	-20.3	142.7	176.4	207.5
EBITDA Margin %	13.36	-1.29	6.86	8.12	9.86
Free Cash Flow (CFO − Capex)	-260.7	-16.5	-22.7	176.7	176.7
Free Cash Flow to Equity	—	-64.3	—	-13.1	—
Free Cash Flow per Basic Share	-10.25	-0.65	-0.89	6.95	6.95
Price to Free Cash Flow	—	—	—	—	7.92
Cash Flow to Net Income	0.86	-2.35	-6.25	7.72	—
Cash Paid for Taxes	83.7	7.1	4.0	28.2	—
Cash Paid for Interest	42.2	62.3	—	86.7	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.